https://stock.noler.com/us/stock/gen-probe-inc https://stock.noler.com/us/stock/gen-probe-inc/accounts-payable https://stock.noler.com/us/stock/gen-probe-inc/accounts-receivable https://stock.noler.com/us/stock/gen-probe-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/gen-probe-inc/accrued-advertising-current https://stock.noler.com/us/stock/gen-probe-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/gen-probe-inc/accrued-income-taxes-noncurrent https://stock.noler.com/us/stock/gen-probe-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/gen-probe-inc/accrued-royalties-current https://stock.noler.com/us/stock/gen-probe-inc/accumulated-depreciation https://stock.noler.com/us/stock/gen-probe-inc/acquired-finite-lived-intangible-asset-amount https://stock.noler.com/us/stock/gen-probe-inc/acquired-indefinite-lived-intangible-asset-amount https://stock.noler.com/us/stock/gen-probe-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/gen-probe-inc/acquisition-contingent-consideration-arrangements-range-of-outcomes-value-high https://stock.noler.com/us/stock/gen-probe-inc/acquisitions https://stock.noler.com/us/stock/gen-probe-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/gen-probe-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/gen-probe-inc/advertising-expense https://stock.noler.com/us/stock/gen-probe-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/gen-probe-inc/amended-reports-10-q https://stock.noler.com/us/stock/gen-probe-inc/amortization-of-acquired-intangible-assets https://stock.noler.com/us/stock/gen-probe-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/gen-probe-inc/aoci https://stock.noler.com/us/stock/gen-probe-inc/asset-retirement-obligations-noncurrent https://stock.noler.com/us/stock/gen-probe-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-debt-maturities-after-five-through-ten-years-amortized-cost https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-debt-maturities-after-five-through-ten-years-fair-value https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-debt-maturities-after-one-through-five-years-amortized-cost https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-debt-maturities-after-one-through-five-years-fair-value https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-debt-maturities-amortized-cost https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-debt-maturities-within-one-year-amortized-cost https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-debt-maturities-within-one-year-fair-value https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-gross-realized-gains https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-gross-realized-losses https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-gross-unrealized-gain https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-gross-unrealized-gains https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-gross-unrealized-loss https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-gross-unrealized-losses https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-in-unrealized-loss-positions-qualitative-disclosure-number-of-positions https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-unrealized-loss-position-12-months-or-longer-aggregate-losses https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-unrealized-loss-position-12-months-or-longer-aggregate-losses-1 https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-unrealized-loss-position-less-than-12-months-aggregate-losses https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-unrealized-loss-position-less-than-12-months-aggregate-losses-1 https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-unrealized-loss-position-less-than-twelve-months-fair-value https://stock.noler.com/us/stock/gen-probe-inc/available-for-sale-unrealized-loss-position-twelve-months-or-longer-fair-value https://stock.noler.com/us/stock/gen-probe-inc/basic-shares https://stock.noler.com/us/stock/gen-probe-inc/business-acquisition-contingent-consideration-at-fair-value https://stock.noler.com/us/stock/gen-probe-inc/business-acquisition-contingent-consideration-potential-cash-payment https://stock.noler.com/us/stock/gen-probe-inc/business-acquisition-purchase-price-allocation-amortizable-intangible-assets https://stock.noler.com/us/stock/gen-probe-inc/buybacks-payments-for-repurchase-of-other-equity https://stock.noler.com/us/stock/gen-probe-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/gen-probe-inc/buybacks-shares-repurchased https://stock.noler.com/us/stock/gen-probe-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/gen-probe-inc/capital-expenditures https://stock.noler.com/us/stock/gen-probe-inc/capitalized-computer-software-accumulated-amortization https://stock.noler.com/us/stock/gen-probe-inc/capitalized-computer-software-gross https://stock.noler.com/us/stock/gen-probe-inc/capitalized-computer-software-net https://stock.noler.com/us/stock/gen-probe-inc/capitalized-software-development-costs-for-software-sold-to-customers https://stock.noler.com/us/stock/gen-probe-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/gen-probe-inc/cash-and-equivalents https://stock.noler.com/us/stock/gen-probe-inc/cash-flow-breakdown https://stock.noler.com/us/stock/gen-probe-inc/clinical-trials https://stock.noler.com/us/stock/gen-probe-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/gen-probe-inc/common-stock-value https://stock.noler.com/us/stock/gen-probe-inc/comprehensive-income https://stock.noler.com/us/stock/gen-probe-inc/construction-in-progress-gross https://stock.noler.com/us/stock/gen-probe-inc/contracts-revenue https://stock.noler.com/us/stock/gen-probe-inc/cost-of-goods-sold https://stock.noler.com/us/stock/gen-probe-inc/costs-and-expenses https://stock.noler.com/us/stock/gen-probe-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/gen-probe-inc/current-assets https://stock.noler.com/us/stock/gen-probe-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/gen-probe-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/gen-probe-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/gen-probe-inc/current-liabilities https://stock.noler.com/us/stock/gen-probe-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/gen-probe-inc/deferred-compensation-liability-classified-noncurrent https://stock.noler.com/us/stock/gen-probe-inc/deferred-compensation-liability-current https://stock.noler.com/us/stock/gen-probe-inc/deferred-compensation-liability-current-and-noncurrent https://stock.noler.com/us/stock/gen-probe-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/gen-probe-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/gen-probe-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/gen-probe-inc/deferred-revenue https://stock.noler.com/us/stock/gen-probe-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/gen-probe-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/gen-probe-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/gen-probe-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/gen-probe-inc/deferred-tax-assets-inventory https://stock.noler.com/us/stock/gen-probe-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/gen-probe-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/gen-probe-inc/deferred-tax-assets-net-current https://stock.noler.com/us/stock/gen-probe-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/gen-probe-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/gen-probe-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/gen-probe-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/gen-probe-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits https://stock.noler.com/us/stock/gen-probe-inc/deferred-tax-assets-unrealized-losses-on-available-for-sale-gross https://stock.noler.com/us/stock/gen-probe-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/gen-probe-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/gen-probe-inc/deferred-tax-liabilities-current https://stock.noler.com/us/stock/gen-probe-inc/deferred-tax-liabilities-deferred-expense https://stock.noler.com/us/stock/gen-probe-inc/deferred-tax-liabilities-deferred-expense-other-capitalized-costs https://stock.noler.com/us/stock/gen-probe-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/gen-probe-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/gen-probe-inc/deferred-tax-liabilities-unrealized-gains-on-trading-securities https://stock.noler.com/us/stock/gen-probe-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/gen-probe-inc/depreciation https://stock.noler.com/us/stock/gen-probe-inc/depreciation-and-amortization https://stock.noler.com/us/stock/gen-probe-inc/diluted-shares https://stock.noler.com/us/stock/gen-probe-inc/dilutive-shares https://stock.noler.com/us/stock/gen-probe-inc/disposal-group-not-discontinued-operation-gain-loss-on-disposal https://stock.noler.com/us/stock/gen-probe-inc/effective-tax-rate https://stock.noler.com/us/stock/gen-probe-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/gen-probe-inc/eps https://stock.noler.com/us/stock/gen-probe-inc/eps-basic https://stock.noler.com/us/stock/gen-probe-inc/excess-tax-benefit-from-share-based-compensation-financing-activities https://stock.noler.com/us/stock/gen-probe-inc/excess-tax-benefit-from-share-based-compensation-operating-activities https://stock.noler.com/us/stock/gen-probe-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/gen-probe-inc/fair-value-assets-cash-and-cash-equivalents https://stock.noler.com/us/stock/gen-probe-inc/fair-value-investments https://stock.noler.com/us/stock/gen-probe-inc/financing-cash-flow https://stock.noler.com/us/stock/gen-probe-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/gen-probe-inc/finite-lived-intangible-assets-amortization-expense https://stock.noler.com/us/stock/gen-probe-inc/finite-lived-intangible-assets-future-amortization-expense https://stock.noler.com/us/stock/gen-probe-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/gen-probe-inc/finite-lived-intangible-assets-useful-life-maximum https://stock.noler.com/us/stock/gen-probe-inc/finite-lived-intangible-assets-useful-life-minimum https://stock.noler.com/us/stock/gen-probe-inc/finite-lived-intangible-assets-weighted-average-useful-life https://stock.noler.com/us/stock/gen-probe-inc/finite-lived-license-agreements-gross https://stock.noler.com/us/stock/gen-probe-inc/finite-lived-patents-gross https://stock.noler.com/us/stock/gen-probe-inc/foreign-pretax-income https://stock.noler.com/us/stock/gen-probe-inc/furniture-and-fixtures-gross https://stock.noler.com/us/stock/gen-probe-inc/future-amortization-expense-year-five https://stock.noler.com/us/stock/gen-probe-inc/future-amortization-expense-year-four https://stock.noler.com/us/stock/gen-probe-inc/future-amortization-expense-year-one https://stock.noler.com/us/stock/gen-probe-inc/future-amortization-expense-year-three https://stock.noler.com/us/stock/gen-probe-inc/future-amortization-expense-year-two https://stock.noler.com/us/stock/gen-probe-inc/gain-loss-on-sale-of-equity-investments https://stock.noler.com/us/stock/gen-probe-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/gen-probe-inc/general-and-administrative-expense https://stock.noler.com/us/stock/gen-probe-inc/geographic-long-lived-assets-in-entitys-country-of-domicile https://stock.noler.com/us/stock/gen-probe-inc/geographic-long-lived-assets-in-foreign-countries https://stock.noler.com/us/stock/gen-probe-inc/geographic-revenue-from-external-customers-attributed-to-entitys-country-of-domicile https://stock.noler.com/us/stock/gen-probe-inc/geographic-revenue-from-external-customers-attributed-to-foreign-countries https://stock.noler.com/us/stock/gen-probe-inc/goodwill https://stock.noler.com/us/stock/gen-probe-inc/goodwill-acquired https://stock.noler.com/us/stock/gen-probe-inc/goodwill-and-intangible-asset-impairment https://stock.noler.com/us/stock/gen-probe-inc/goodwill-gross https://stock.noler.com/us/stock/gen-probe-inc/goodwill-impaired-accumulated-impairment-loss https://stock.noler.com/us/stock/gen-probe-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/gen-probe-inc/goodwill-purchase-accounting-adjustments https://stock.noler.com/us/stock/gen-probe-inc/goodwill-translation-and-purchase-accounting-adjustments https://stock.noler.com/us/stock/gen-probe-inc/gross-profit https://stock.noler.com/us/stock/gen-probe-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/gen-probe-inc/income-tax https://stock.noler.com/us/stock/gen-probe-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/gen-probe-inc/income-taxes-paid https://stock.noler.com/us/stock/gen-probe-inc/income-taxes-paid-2 https://stock.noler.com/us/stock/gen-probe-inc/increase-decrease-in-accounts-and-other-receivables https://stock.noler.com/us/stock/gen-probe-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/gen-probe-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/gen-probe-inc/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/gen-probe-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/gen-probe-inc/increase-decrease-in-other-accrued-liabilities https://stock.noler.com/us/stock/gen-probe-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/gen-probe-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/gen-probe-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/gen-probe-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/gen-probe-inc/insider-transactions-other https://stock.noler.com/us/stock/gen-probe-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/gen-probe-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/gen-probe-inc/interest-expense https://stock.noler.com/us/stock/gen-probe-inc/interest-paid https://stock.noler.com/us/stock/gen-probe-inc/interest-payable-current https://stock.noler.com/us/stock/gen-probe-inc/inventory https://stock.noler.com/us/stock/gen-probe-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/gen-probe-inc/inventory-raw-materials-and-supplies-net-of-reserves https://stock.noler.com/us/stock/gen-probe-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/gen-probe-inc/investing-cash-flow https://stock.noler.com/us/stock/gen-probe-inc/investment-building-and-building-improvements https://stock.noler.com/us/stock/gen-probe-inc/investment-income-interest-and-dividend https://stock.noler.com/us/stock/gen-probe-inc/investments-fair-value-disclosure https://stock.noler.com/us/stock/gen-probe-inc/land https://stock.noler.com/us/stock/gen-probe-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/gen-probe-inc/licenses-revenue https://stock.noler.com/us/stock/gen-probe-inc/line-of-credit-facility-amount-outstanding https://stock.noler.com/us/stock/gen-probe-inc/line-of-credit-facility-increase-additional-borrowings https://stock.noler.com/us/stock/gen-probe-inc/line-of-credit-facility-interest-rate-at-period-end https://stock.noler.com/us/stock/gen-probe-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/gen-probe-inc/machinery-and-equipment-gross https://stock.noler.com/us/stock/gen-probe-inc/marketable-securities https://stock.noler.com/us/stock/gen-probe-inc/marketable-securities-current https://stock.noler.com/us/stock/gen-probe-inc/marketable-securities-noncurrent https://stock.noler.com/us/stock/gen-probe-inc/minority-interest-ownership-percentage-by-noncontrolling-owners https://stock.noler.com/us/stock/gen-probe-inc/net-change-in-cash https://stock.noler.com/us/stock/gen-probe-inc/net-income https://stock.noler.com/us/stock/gen-probe-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/gen-probe-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/gen-probe-inc/new-shares-sold https://stock.noler.com/us/stock/gen-probe-inc/non-hedging-derivatives-loss https://stock.noler.com/us/stock/gen-probe-inc/oci-available-for-sale-adjustment-net-of-tax-change https://stock.noler.com/us/stock/gen-probe-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/gen-probe-inc/oci-net-of-tax-change https://stock.noler.com/us/stock/gen-probe-inc/oci-securities-sale-reclassification-net-of-tax https://stock.noler.com/us/stock/gen-probe-inc/oci-securities-sale-reclassification-tax https://stock.noler.com/us/stock/gen-probe-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/gen-probe-inc/oci-unrealized-holding-gain-loss-on-securities-arising-tax https://stock.noler.com/us/stock/gen-probe-inc/operating-cash-flow https://stock.noler.com/us/stock/gen-probe-inc/operating-income https://stock.noler.com/us/stock/gen-probe-inc/operating-leases-future-minimum-payments-receivable https://stock.noler.com/us/stock/gen-probe-inc/operating-leases-future-minimum-payments-receivable-current https://stock.noler.com/us/stock/gen-probe-inc/operating-leases-future-minimum-payments-receivable-in-five-years https://stock.noler.com/us/stock/gen-probe-inc/operating-leases-future-minimum-payments-receivable-in-four-years https://stock.noler.com/us/stock/gen-probe-inc/operating-leases-future-minimum-payments-receivable-in-three-years https://stock.noler.com/us/stock/gen-probe-inc/operating-leases-future-minimum-payments-receivable-in-two-years https://stock.noler.com/us/stock/gen-probe-inc/operating-leases-future-minimum-payments-receivable-thereafter https://stock.noler.com/us/stock/gen-probe-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/gen-probe-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/gen-probe-inc/other-assets-fair-value-disclosure https://stock.noler.com/us/stock/gen-probe-inc/other-current-assets https://stock.noler.com/us/stock/gen-probe-inc/other-income https://stock.noler.com/us/stock/gen-probe-inc/other-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/gen-probe-inc/other-noncurrent-assets https://stock.noler.com/us/stock/gen-probe-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/gen-probe-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/gen-probe-inc/other-receivables https://stock.noler.com/us/stock/gen-probe-inc/other-than-temporary-impairment-losses-investments-available-for-sale-securities https://stock.noler.com/us/stock/gen-probe-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/gen-probe-inc/paid-in-capital-tax-effect-from-share-based-compensation https://stock.noler.com/us/stock/gen-probe-inc/patents-active https://stock.noler.com/us/stock/gen-probe-inc/patents-expired https://stock.noler.com/us/stock/gen-probe-inc/patents-pending https://stock.noler.com/us/stock/gen-probe-inc/patents-rejected https://stock.noler.com/us/stock/gen-probe-inc/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/gen-probe-inc/payments-for-software https://stock.noler.com/us/stock/gen-probe-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/gen-probe-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/gen-probe-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/gen-probe-inc/payments-to-acquire-other-investments https://stock.noler.com/us/stock/gen-probe-inc/payments-to-develop-software https://stock.noler.com/us/stock/gen-probe-inc/preferred-shares-facts https://stock.noler.com/us/stock/gen-probe-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/gen-probe-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/gen-probe-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/gen-probe-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/gen-probe-inc/preferred-stock-value https://stock.noler.com/us/stock/gen-probe-inc/prepaid-expense-current https://stock.noler.com/us/stock/gen-probe-inc/prepaid-taxes https://stock.noler.com/us/stock/gen-probe-inc/pretax-income-domestic https://stock.noler.com/us/stock/gen-probe-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/gen-probe-inc/proceeds-from-divestiture-of-businesses-net-of-cash-divested https://stock.noler.com/us/stock/gen-probe-inc/proceeds-from-repayments-of-debt https://stock.noler.com/us/stock/gen-probe-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/gen-probe-inc/proceeds-from-sale-of-other-investments https://stock.noler.com/us/stock/gen-probe-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/gen-probe-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/gen-probe-inc/product-warranty-accrual-classified-current https://stock.noler.com/us/stock/gen-probe-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/gen-probe-inc/property-plant-equipment https://stock.noler.com/us/stock/gen-probe-inc/public-float https://stock.noler.com/us/stock/gen-probe-inc/purchase-obligations-balance-on-fifth-anniversary https://stock.noler.com/us/stock/gen-probe-inc/purchase-obligations-balance-on-first-anniversary https://stock.noler.com/us/stock/gen-probe-inc/purchase-obligations-balance-on-fourth-anniversary https://stock.noler.com/us/stock/gen-probe-inc/purchase-obligations-balance-on-second-anniversary https://stock.noler.com/us/stock/gen-probe-inc/purchase-obligations-balance-on-third-anniversary https://stock.noler.com/us/stock/gen-probe-inc/purchase-obligations-balance-sheet-amount https://stock.noler.com/us/stock/gen-probe-inc/purchase-obligations-due-after-five-years https://stock.noler.com/us/stock/gen-probe-inc/recognition-of-deferred-revenue https://stock.noler.com/us/stock/gen-probe-inc/research-and-development https://stock.noler.com/us/stock/gen-probe-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/gen-probe-inc/restructuring-and-related-cost-cost-incurred-to-date https://stock.noler.com/us/stock/gen-probe-inc/restructuring-and-related-cost-expected-cost https://stock.noler.com/us/stock/gen-probe-inc/restructuring-and-related-cost-incurred-cost https://stock.noler.com/us/stock/gen-probe-inc/restructuring-reserve https://stock.noler.com/us/stock/gen-probe-inc/restructuring-reserve-period-expense https://stock.noler.com/us/stock/gen-probe-inc/restructuring-reserve-settled-with-cash https://stock.noler.com/us/stock/gen-probe-inc/restructuring-reserve-translation-adjustment https://stock.noler.com/us/stock/gen-probe-inc/retained-earnings https://stock.noler.com/us/stock/gen-probe-inc/revenue https://stock.noler.com/us/stock/gen-probe-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/gen-probe-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/gen-probe-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/gen-probe-inc/sec-filings-10-12b https://stock.noler.com/us/stock/gen-probe-inc/sec-filings-10-12g https://stock.noler.com/us/stock/gen-probe-inc/sec-filings-10-k https://stock.noler.com/us/stock/gen-probe-inc/sec-filings-10-q https://stock.noler.com/us/stock/gen-probe-inc/sec-filings-15-12g https://stock.noler.com/us/stock/gen-probe-inc/sec-filings-25-nse https://stock.noler.com/us/stock/gen-probe-inc/sec-filings-8-k https://stock.noler.com/us/stock/gen-probe-inc/sec-filings-ars https://stock.noler.com/us/stock/gen-probe-inc/sec-filings-ct-order https://stock.noler.com/us/stock/gen-probe-inc/sec-filings-def-14a https://stock.noler.com/us/stock/gen-probe-inc/sec-filings-def-14c https://stock.noler.com/us/stock/gen-probe-inc/sec-filings-defa14a https://stock.noler.com/us/stock/gen-probe-inc/sec-filings-defm14a https://stock.noler.com/us/stock/gen-probe-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/gen-probe-inc/sec-filings-pre-14c https://stock.noler.com/us/stock/gen-probe-inc/sec-filings-prem14a https://stock.noler.com/us/stock/gen-probe-inc/sec-filings-prer14a https://stock.noler.com/us/stock/gen-probe-inc/sec-filings-s-4 https://stock.noler.com/us/stock/gen-probe-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/gen-probe-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/gen-probe-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/gen-probe-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/gen-probe-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/gen-probe-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/gen-probe-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/gen-probe-inc/shareholders-equity https://stock.noler.com/us/stock/gen-probe-inc/shares-authorized https://stock.noler.com/us/stock/gen-probe-inc/shares-issued https://stock.noler.com/us/stock/gen-probe-inc/shipping-handling-and-transportation-costs https://stock.noler.com/us/stock/gen-probe-inc/short-term-borrowings https://stock.noler.com/us/stock/gen-probe-inc/stock-award-shares-issued-in-period https://stock.noler.com/us/stock/gen-probe-inc/stock-based-compensation https://stock.noler.com/us/stock/gen-probe-inc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/gen-probe-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/gen-probe-inc/stock-compensation-unrecognized-cost-recognition-period https://stock.noler.com/us/stock/gen-probe-inc/stock-compensation-unrecognized-costs https://stock.noler.com/us/stock/gen-probe-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/gen-probe-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/gen-probe-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/gen-probe-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/gen-probe-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/gen-probe-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/gen-probe-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/gen-probe-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/gen-probe-inc/stock-options-exercises-in-period https://stock.noler.com/us/stock/gen-probe-inc/stock-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/gen-probe-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/gen-probe-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/gen-probe-inc/stock-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/gen-probe-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/gen-probe-inc/stock-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/gen-probe-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/gen-probe-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/gen-probe-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/gen-probe-inc/stock-options-outstanding-remaining-term https://stock.noler.com/us/stock/gen-probe-inc/stock-repurchase-program-authorized-amount https://stock.noler.com/us/stock/gen-probe-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/gen-probe-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/gen-probe-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/gen-probe-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/gen-probe-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/gen-probe-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/gen-probe-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/gen-probe-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/gen-probe-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/gen-probe-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/gen-probe-inc/total-assets https://stock.noler.com/us/stock/gen-probe-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/gen-probe-inc/undistributed-earnings-allocated-to-participating-securities https://stock.noler.com/us/stock/gen-probe-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/gen-probe-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/gen-probe-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/gen-probe-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/gen-probe-inc/utb-reduction-from-statute-lapse https://stock.noler.com/us/stock/gen-probe-inc/utb-that-would-impact-effective-tax-rate